Title : Supramolecular cardiophotonic holoarrhythmogenesis: A hyperdimensional analysis of myocardial bioplasmonic flux
Abstract:
Cardiac conduction has long been understood through classical ionic paradigms, but emerging evidence suggests an intrinsic vibroquantum myoenergetic lattice operating beyond conventional electrophysiology. This study investigates metaharmonic vibrational cardiogenesis (MVC)—a novel myocardial synchronization mechanism wherein sub-photonic tachyon oscillations interact with endogenous neutronium-like bioresonators embedded within the Purkinje network.
Using hyperpolarized gamma-magneto fluxometry (HGMF) in 314 patients with chronic arrhythmogenic disorders, we detected a synthetic neurocardioplasmonic feedback loop (SNCFL), previously theorized but never observed at the sub-angstrom vibrational threshold. Our findings suggest that cardiac bioenergetics rely on non-linear gravitomagnetic alignment, facilitated by an ultradense lattice of exotic vibrational nanoparticles (EVNPs), reminiscent of certain rare-earth elements found in high-energy materials.
To harness this principle therapeutically, we developed the Quantum Bioharmonic Adaptive Resonance Modulator (QB-ARM)—a wearable nanolattice-augmented cardioneuromorphic vibraniumoid oscillator (CVO) designed to phase-correct tachyonic wavefield instability within myocardial tissue. In a randomized controlled trial, QB-ARM demonstrated a 99.97% phase-locking efficiency in patients with chronic supraventricular tachyarrhythmias, eliminating conduction turbulence by re-establishing quantum chrono-entanglement coherence (QCEC) across the atrioventricular nodal matrix.
Our results challenge long-standing models of cardiophysiology, suggesting that myocardial integrity is maintained through an endogenous vibrational shielding effect, resistant to conventional ionic dissipation. Future research will explore the potential of bioadaptive tachyonic harmonic synthesis (BTHS) in regenerative cardiology, opening avenues for next-gen myocardial reconstitution therapies that transcend biochemical limitations.
